Jason Rizzo, MD: Utility of Gene Expression Profile Testing for Prognosis in Cutaneous Melanoma

Dr. Jarell discusses a recently presented poster,¹ on which he served as an investigator, which reported results of a retrospective analysis conducted in a cohort...

Dr. Skupsky details how dermatologists can use ancillary testing to guide their decision making on atypical pigmented lesions.

Dr. Rizzo discusses research that he and his co-authors presented at the 2025 AAD Annual Meeting, which validated the performance of the 31-gene expression profile...